Home › NDC Lookup › 00536-1302-97
🧴image loading
(from DailyMed)

Anti Nausea dextrose(glucose),Levulose(fructose),Phosphoric acid 1.87 g/5mL; 1.87 g/5mL; 21.5 mg/5mL Liquid — NDC 0536-1302-97 (Billing 00536-1302-97)

by RUGBY LABORATORIES · 1 BOTTLE in 1 CARTON / 118 mL in 1 BOTTLE

This is a package of Anti Nausea dextrose(glucose),Levulose(fructose),Phosphoric acid 1.87 g/5mL; 1.87 g/5mL; 21.5 mg/5mL Liquid from RUGBY LABORATORIES, marketed since Sep 2020 and currently FDA-listed; retail pharmacies pay about $0.0235 per mL (NADAC). It is this product's only package size.

NDC 00536-1302-97
🏷️ FDA NDC (as labeled) 0536-1302-97 billing pads the labeler segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 0536-1302-97 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
0536 labeler · 1302 product · 97 package
Package marketed since
Sep 9, 2020
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 0536130297 9
Medicaid fills, this package
18 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0536-1302-97
Product NDC 0536-1302
11-digit billing NDC 00536130297
NCPDP billing unit ML — per mL (volume)
RxCUI 318146
UNII IY9XDZ35W2, 6YSS42VSEV, E4GA8884NN
SPL Set ID 8506b4ab-a19e-4b0d-aa98-143bf75a1171
DEA schedule Non-controlled
Marketing category UNAPPROVED DRUG OTHER
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2020-09-09
Route ORAL
Dosage form LIQUID
Substance DEXTROSE, UNSPECIFIED FORM; FRUCTOSE; PHOSPHORIC ACID

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 50309903602000
GPI class Anti-Nausea
GCN Seq No 004698
GCN 73710
HICL code 015060
Ingredient (HICL) Phosphorated Carbo(Dext-Fruct)
HIC1 code H
Therapeutic class — broad (HIC1) Nervous System (Except Autonomic)
HIC2 code H6
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Midbrain
HIC3 code H6J
Therapeutic class — specific (HIC3) Antiemetic/Antivertigo Agents
AHFS code 56:22.92.00
AHFS class Antiemetics, Miscellaneous
FDB label name ANTI-NAUSEA LIQUID
FDB brand name Anti-Nausea
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 004698
  • GCN: 73710
  • GPI-14 (Medi-Span): 50309903602000
  • HICL (First Databank): 015060
  • AHFS class code: 56:22.92.00
  • RxCUI (RxNorm): 318146
Why two NDCs? The FDA registers this code as 0536-1302-97 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00536-1302-97. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Carbohydrates class.

Drug family (ATC) Carbohydrates
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name ANTI-NAUSEA LIQUID Ingredient Phosphorated Carbo(Dext-Fruct)
🧪 What is this product?

This is an unapproved over-the-counter oral liquid product containing dextrose (glucose), fructose, and phosphoric acid. The sugars are intended to provide quick carbohydrate calories, while phosphoric acid is commonly included in nausea relief products, though the exact mechanism in this formulation is not established. The product is marketed for nausea but has not received FDA approval as a drug.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $0.024 $2.77 / 118 ml
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per mL) — tap or hover for the price & month
Nov 2021 Jul 2022 Jan 2026 Sep 2026 $0.027 $0.016
▲ Up 18% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
00536-1302-97 You're viewing this Main listing 1 BOTTLE in 1 CARTON / 118 mL in 1 BOTTLE 2020-09-09 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Anti Nausea 1.87 g/5mL; 1.87 g/5mL; 21.5 mg/5mLthis 00536-1302-97 RUGBY 1 bottle $0.024 — Availability likely —
Good Neighbor Anti Nausea Cherry Flavor 1.87 g/5mL; 1.87 g/5mL; 21.5 mg/5mL 46122-0729-26 AMERISOURCE 1 bottle $0.024 — Availability likely —
Anti Nausea 1.87 g/5mL; 1.87 g/5mL; 21.5 mg/5mL 70000-0052-01 Cardinal 1 bottle $0.024 — Availability likely —
QUALITY CHOICE Anti-Nausea 1.87 g/5mL; 1.87 g/5mL; 21.5 mg/5mL 83324-0217-04 QUALITY 1 bottle $0.024 — Availability likely —
Walgreen Anti Nausea Cherry Flavor 1.87 g/5mL; 1.87 g/5mL; 21.5 mg/5mL 00363-7080-04 WALGREENS 1 bottle — — FDA listed —
Walgreen Children Anti Nausea 1.87 g/5mL; 1.87 g/5mL; 21.5 mg/5mL 00363-7081-04 WALGREENS 1 bottle — — FDA listed —
Kroger Anti Nausea Cherry Flavor 1.87 g/5mL; 1.87 g/5mL; 21.5 mg/5mL 30142-0708-04 KROGER 1 bottle — — FDA listed —
Anti Nausea Liquid 1.87 g/5mL; 1.87 g/5mL; 21.5 mg/5mL 36800-0708-04 TOPCO 1 bottle — — FDA listed —
HEB Anti Nausea 1.87 g/5mL; 1.87 g/5mL; 21.5 mg/5mL 37808-0883-04 HEB 1 bottle — — FDA listed —
Meijer Anti Nausea 1.87 g/5mL; 1.87 g/5mL; 21.5 mg/5mL 41250-0495-04 MEIJER 1 bottle — — FDA listed —
Discount Drug Mart nausea control Cherry Flavor 1.87 g/5mL; 1.87 g/5mL; 21.5 mg/5mL 53943-0708-04 DISCOUNT 1 bottle — — FDA listed —
Anti Nausea Liquid Cherry Flavor 1.87 g/5mL; 1.87 g/5mL; 21.5 mg/5mL 63868-0704-04 QUALITY 1 bottle — — FDA listed —
Best Choice Anti Nausea Cherry Flavor 1.87 g/5mL; 1.87 g/5mL; 21.5 mg/5mL 63941-0708-04 BEST 1 bottle — — FDA listed —
Emetrol Cherry 1.87 g/5mL; 21.5 mg/5mL; 1.87 g/5mL 65197-0201-04 WellSpring 1 bottle — — FDA listed —
Emetrol Children Mixed Berry 1.87 g/5mL; 21.5 mg/5mL; 1.87 g/5mL 65197-0202-14 WellSpring 1 bottle — — FDA listed —
Premier Value Nausea Control Cherry Flavor 1.87 g/5mL; 1.87 g/5mL; 21.5 mg/5mL 68016-0807-04 PHARMACY 1 bottle — — FDA listed —
CVS Anti Nausea Cherry Flavor 1.87 g/5mL; 1.87 g/5mL; 21.5 mg/5mL 69842-0708-04 CVS 1 bottle — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2020
On the market since
Sep 2020
📍
2026
Currently FDA-listed
6 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color red
FlavorCherry
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerRUGBY LABORATORIES
Labeler code00536
First marketedSep 2020
Product typeHuman Otc Drug
Portfolio149 products on file

More NDCs from RUGBY LABORATORIES labeler code 00536

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 9 words ▾

Uses For relief of upset stomach associated with nausea

⏱️ Dosage and Administration 94 words ▾

Directions for maximum effectiveness never dilute or drink fluids of any kind immediately before or after taking this product repeat dose every 15 minutes or until distress subsides do not take more than 5 doses in 1 hour without consulting a doctor measure only with dosing cup provided. Dosing cup to be used with this product only. Do not use with other products. mL= milliliter age dose adults and children 12 years of age and over 15 mL or 30 mL children 2 to under 12 years of age 5 ml or 10 mL

⚠️ Warnings 87 words ▾

Warnings This product contains fructose and should not be taken by persons with hereditary fructose intolerance (HFI). Do not use if you have allergic reactions to any of the ingredients in this product Ask a doctor before use if you have diabetes Stop use and ask a doctor if symptoms persist, return or get worse If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

🧪 Active Ingredient 17 words ▾

Active ingredients (per 5 mL) Dextrose (glucose) 1.87 g Levulose (fructose) 1.87 g Phosphoric acid 21.5 mg

🧪 Inactive Ingredients 11 words ▾

Inactive ingredients FD&C red no. 40, flavors, glycerin, methylparaben, purified water.

🎯 Purpose 4 words ▾

Purpose Upset Stomach Reliever

📄 Do Not Use 16 words ▾

Do not use if you have allergic reactions to any of the ingredients in this product

📄 Ask a Doctor Before Use If 9 words ▾

Ask a doctor before use if you have diabetes

📄 Stop Use and Ask a Doctor If 13 words ▾

Stop use and ask a doctor if symptoms persist, return or get worse

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 22 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

📄 Package Label / Principal Display Panel 6 words ▾

PACKAGE LABEL Nausea Control Cherry Flavor

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
18
Units reimbursed last 4 qtrs
0
Latest quarter Q1 2026
0Rx
Fee-for-service vs managed care ⓘ
100% MCO
Fee-for-service · 0 Rx Managed care · 18 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: no data reported MN Wisconsin: no data reported WI Michigan: no data reported MI New York: no data reported NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: no data reported OH Pennsylvania: no data reported PA New Jersey: no data reported NJ Massachusetts: no data reported MA California: no data reported CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: no data reported KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
0.00.0
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Anti Nausea (this brand).

Top reported reactions

Fatigue5
Diarrhoea4
Dry Mouth4
Nausea4
Constipation3
Cough2
Neuropathy Peripheral2

Age at onset

Adult3

Reporter sex

0 reports
Male · 29%
Female · 71%

Serious outcomes

Hospitalization6
Life-threatening1
Disabling1
Death1
Reports over time (by year) — tap or hover for the count & year
2022 2023 2024 2026 2 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product Marketed without an FDA application

Listed without an FDA application

This product's marketing category indicates it is marketed without an approved FDA application (no NDA, ANDA, or BLA on file). Having an NDC does not by itself establish FDA approval — the NDC Directory is a listing system, not an approval decision. Approval-linked data such as Orange Book therapeutic-equivalence ratings therefore does not apply.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) ✓ Available
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) ✓ Available
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Drug Other". Products approved under an application carry an NDA, ANDA, or BLA number.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by RUGBY LABORATORIES. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
RUGBY LABORATORIES is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 00536-1299-01 · Rugby 00536-1303-75 · RUGBY →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.